Recently, artificial intelligence applications such as machine learning and deep learning have become valuable tools for highly accurate differentiation between IDH wildtype and IDH mutant gliomas in MRI-based applications [243,244,245,246,247,248]. This evidence concerns the gene IDH1 and central nervous system cancer.